Altshuler Shaham’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-168
Closed -$3.84K 408
2024
Q3
$3.84K Buy
168
+40
+31% +$904 ﹤0.01% 260
2024
Q2
$2.94K Buy
128
+36
+39% +$1.11K ﹤0.01% 294
2024
Q1
$3.64K Buy
+92
New +$3.64K ﹤0.01% 279
2023
Q1
Sell
-691
Closed -$25.8K 442
2022
Q4
$25.8K Sell
691
-67
-9% -$2.59K ﹤0.01% 338
2022
Q3
$31K Buy
+758
New +$28.1K ﹤0.01% 311
2021
Q4
Sell
-941
Closed -$40K 612
2021
Q3
$40K Buy
+941
New +$47.4K ﹤0.01% 439
2020
Q2
Sell
-257
Closed -$12K 499
2020
Q1
$12K Buy
257
+38
+17% +$2.28K ﹤0.01% 280
2019
Q4
$14K Buy
219
+75
+52% +$4.58K ﹤0.01% 304
2019
Q3
$8K Buy
+144
New +$8.92K ﹤0.01% 318

Other funds holding NRC

Altshuler Shaham's NRC Position: Q4 2024 in Review

Altshuler Shaham sold out of NRC Health Common Stock (NRC) in Q4 2024, closing a stake of 168 shares — an estimated $3.84K sold.

Altshuler Shaham first reported a position in NRC in Q3 2019 and held it in 9 quarters. The position peaked at $40K in Q3 2021. 133 funds tracked by Wall St. Rank hold NRC as of Q4 2024.

  • Altshuler Shaham reported no remaining NRC Health Common Stock position as of Q4 2024 after selling out during the quarter.
  • Altshuler Shaham sold 168 NRC Health Common Stock shares in Q4 2024, an estimated $3.84K.
  • Altshuler Shaham first reported a position in NRC Health Common Stock in Q3 2019 and held it in 9 quarters.
  • Altshuler Shaham's NRC Health Common Stock position peaked at $40K in Q3 2021.
  • 133 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q4 2024.

Based on Altshuler Shaham's 13F filing for Q4 2024, filed 13 Feb 2025.